Interdisciplinary Stem Cell Training Grant at UCSD III
Grant Award Details
Grant Type:
Grant Number:
EDUC4-12804
Investigator(s):
Award Value:
$5,366,188
Status:
Active
Progress Reports
Reporting Period:
Year 1
Reporting Period:
Year 2
Reporting Period:
Year 3
Grant Application Details
Application Title:
Interdisciplinary Stem Cell Training Grant at UCSD III
Public Abstract:
Our proposed training program serves as a catalyst and foundation for expanding stem cell biology efforts at UC San Diego. We are aided in our goals by the unique La Jolla scientific community, which has become a premier location in the world to pursue innovative biomedical research. We have an unusually interdisciplinary and highly collaborative scientific community where research and training collaborations have flourished across traditional institutional and scientific boundaries. Our goal is to train basic scientists, physician-scientists, and bioengineers who will pursue innovative stem cell and regenerative medicine interdisciplinary research driven by their understanding of Basic and Clinical Sciences merged with advanced engineering and bioinformatic methods. Trainees at UC San Diego will have access to state-of-the-art stem cells and gene therapy facilities, plus the opportunity to witness how basic fundamental discoveries can be translated into the clinics. In addition, UCSD is unique for its combination of assets that are committed to stem cell and regenerative medicine research, many of which qualify as "one of the first" in the nation, including i) a stand-alone Division of Regenerative Medicine within the Department of Medicine; ii) an active outpatient facility at the Koman Outpatient Pavilion and an inpatient capacity with the Cell and Regenerative Medicine Service within the Medical Center system; iii) one of the original Alpha Stem Cell Clinics for clinical research, and iv) an existing course in Translational Regenerative Medicine that can contribute to a Master’s Degree in clinical research or a certificate in translational research. We also give substantial exposure to quantitative, ethical, and theoretical approaches to biological and medical problems in regenerative medicine, including a collaboration with our new School of Public Health to enhance the positive impact and accessibility of new therapies for patients across broad socioeconomic and ethnic groups. Our approach is to build on each trainee’s foundation of basic or clinical knowledge and provide: 1) Rigorous education in the principles and applications of pluripotent and adult stem biology in humans and model organisms; 2) Research training in evolutionary, computational, and bioengineering methods that can use stem cells to attack problems of basic and clinical science and eventually develop new therapies; and 3) Education in the ethical, legal, social, and economic issues associated with stem cell biology and regenerative medicine. Thus, future stem cell trainees at UCSD are positioned to become leaders in this field in the upcoming years.
Statement of Benefit to California:
This training opportunity will bring the following benefits to California:
1-Training the next generation of stem cell biologists. The strength of our commitment to research training, the value of our experience, and the positive effect of strong mentoring is manifest in the success of our past group of CIRM trainees, who have published an outstanding volume of high-impact papers in the field, gaining excellent careers in industry, clinical endeavors, and academia, with many becoming faculty members themselves, thus extending the impact of the training program to new generations of scientists. Moreover, many of these past trainees have also received other prestigious prizes, awards, and fellowships, including the Hertzberg-Schecter Prize for Stem Cell Research, the Product Development Breakthrough Award, the Larry Hillblon Foundation fellowship, NIH K99/R00s, Ruth L. Krischetein fellowship, best dissertation thesis, best poster in meetings, etc. We have a total of 87 past CIRM trainees from 49 different UCSD mentors. Of all trainees, 57% of these were women, and 81% continue researching in the USA (including 72% in California).
2-Health and Economic Benefits. The work from our CIRM trainees has led to new treatment and several ongoing clinical trials (including spinal cord injury, different types of cancer, Alzheimer's Disease). Moreover, the work from our trainees becomes inventions and patents, many being licensed by our faculty-based spin-offs based in California.
3-Public communication and outreach. Californians will also benefit from our proposed dissemination and outreach activities. Our strong partnership with UCTV has resulted in unique collaborations like Stem Cell Science with Alysson Muotri, to produce high-quality, easy-to-understand, 12-15 minutes videos about stem cells and their applications. To effectively reach diverse populations, including non-English-speaking people and racial and ethnic minorities, these episodes are translated into both Spanish and Portuguese. A pilot video of this channel received the 2018 Telly Award for excellence in science communication and, another episode received another Telly Award in 2019. This initiative alone brought in over 1 million views across its first season and consistently ranked in the top position for programming across all of the Universities of California. We also established the “Closer Look” online series, aimed to stimulate expert conversation between a basic scientist and a clinician about emerging stem cell research and clinical strategies tackling a variety of diseases. This has become a trendy venue for our scientists to meet and answer questions from the public. The average attendance is about 300 people by zoom. All the videos are recorded and made available on YouTube. We will also reinstitute an annual Stem Cell Day celebration and bring trainees to present their work to the public.
Publications
- Mol Psychiatry (2022): Advancing preclinical models of psychiatric disorders with human brain organoid cultures. (PubMed: 35948659)
- iScience (2024): Atypical KCNQ1/Kv7 channel function in a neonatal diabetes patient: Hypersecretion preceded the failure of pancreatic beta-cells. (PubMed: 39055936)
- FEMS Microbiol Lett (2023): Bridging the gap with bacterial art. (PubMed: 37028930)
- Nat Commun (2022): CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma. (PubMed: 36309522)
- Nat Commun (2024): Charting and probing the activity of ADARs in human development and cell-fate specification. (PubMed: 39537590)
- Biomaterials (2023): Conductive electrospun polymer improves stem cell-derived cardiomyocyte function and maturation. (PubMed: 37898021)
- J Mol Endocrinol (2024): Conserved and divergent features of trophoblast stem cells. (PubMed: 38276878)
- Elife (2023): Dermomyotome-derived endothelial cells migrate to the dorsal aorta to support hematopoietic stem cell emergence. (PubMed: 37695317)
- J Neurophysiol (2024): Development of neuronal timescales in human cortical organoids and rat hippocampus dissociated cultures. (PubMed: 39015071)
- Proc Natl Acad Sci U S A (2023): OGT controls mammalian cell viability by regulating the proteasome/mTOR/ mitochondrial axis. (PubMed: 36626549)
- J Cell Sci (2022): Proteomic analysis of the actin cortex in interphase and mitosis. (PubMed: 35892282)
- Front Bioeng Biotechnol (2022): Recent advancements and future requirements in vascularization of cortical organoids. (PubMed: 36406234)
- Mol Ther (2023): RNA editing: Expanding the potential of RNA therapeutics. (PubMed: 36620962)
- Nat Biomed Eng (2024): Robust genome and cell engineering via in vitro and in situ circularized RNAs. (PubMed: 39187662)
- Cell Mol Life Sci (2022): The role of BMP4 signaling in trophoblast emergence from pluripotency. (PubMed: 35877048)
- Dev Cell (2023): Understanding cell fate acquisition in stem-cell-derived pancreatic islets using single-cell multiome-inferred regulomes. (PubMed: 37040771)